Literature DB >> 24460763

Derivation, validation and comparative performance of a simplified chest X-ray score for assessing the severity and outcome of pulmonary tuberculosis.

Eric Walter Pefura-Yone1, Christopher Kuaban, Serges Auguste Assamba-Mpom, Boniface Moifo, André Pascal Kengne.   

Abstract

INTRODUCTION: To derive and validate against the Ralph et al. score, a simplified chest X-ray (CXR) score (SCS) for predicting the outcome of smear-positive pulmonary tuberculosis (SPPTB) among patients with high prevalence of human immunodeficiency virus (HIV) infection.
METHODS: CXR for 636 SPPTB patients (377 men, median age 31 years) from the Yaounde Jamot Hospital (Cameroon) were examined for the presence of tuberculosis lesions, and estimation of the proportion of lungs affected. SPPTB's evolution was based on sputum smear examination after 2 months of treatments. Logistic regressions were used to derive the SCS with internal validation via bootstrap resampling. Receiver operating characteristic curves (AUC) analyses were used to validate, determine of the optimal cut-offs and compare models' performance.
RESULTS: HIV co-infection was present in 191 (30%) patients. Sputum smear non-conversion was found in 45 (7.1) patients after 2 months of treatment. The SCS was expressed as proportion of lung affected plus 23 if cavitation is present. The AUC (95% confidence interval) was 0.718 (0.640-0.795), with little variation in bootstrap validation, and no sizable difference from the Ralph et al. model [0.714 (0.633-0.7860), P = 0.717 for the difference). Both models had good calibration (Hosmer-Lemeshow P ≥ 0.183). The optimal cut-off for predicting non-conversion of the sputum at 2 months was 52 for the SCS (sensitivity/specificity 66.7%/62.8%) and 74.5 (62.2%/74.3%) with Ralph et al. score.
CONCLUSIONS: The outcome of SPPTB among patients with high prevalence of HIV can acceptably be predicted by simple scores comprising baseline CXR variables, including the Ralph et al. score and the SCS from this study.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  calibration; chest X-ray; discrimination; prediction; pulmonary tuberculosis

Mesh:

Substances:

Year:  2014        PMID: 24460763     DOI: 10.1111/crj.12112

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  3 in total

Review 1.  Assessment of treatment response in tuberculosis.

Authors:  Neesha Rockwood; Elsa du Bruyn; Thomas Morris; Robert J Wilkinson
Journal:  Expert Rev Respir Med       Date:  2016-03-31       Impact factor: 3.772

Review 2.  Systematic review of prediction models for pulmonary tuberculosis treatment outcomes in adults.

Authors:  Lauren S Peetluk; Felipe M Ridolfi; Peter F Rebeiro; Dandan Liu; Valeria C Rolla; Timothy R Sterling
Journal:  BMJ Open       Date:  2021-03-02       Impact factor: 2.692

3.  Development and validation of a prognostic score during tuberculosis treatment.

Authors:  Eric Walter Pefura-Yone; Adamou Dodo Balkissou; Virginie Poka-Mayap; Hadja Koté Fatime-Abaicho; Patrick Thierry Enono-Edende; André Pascal Kengne
Journal:  BMC Infect Dis       Date:  2017-04-08       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.